Search: onr:"swepub:oai:lup.lub.lu.se:7919fa8b-bb3a-4d0a-b1e4-86559aa784b0" >
Power-assisted Lipo...
-
Bloom, Joshua ATufts Medical Center
(author)
Power-assisted Liposuction for Lymphedema : A Cost-utility Analysis
- Article/chapterEnglish2022
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:7919fa8b-bb3a-4d0a-b1e4-86559aa784b0
-
https://lup.lub.lu.se/record/7919fa8b-bb3a-4d0a-b1e4-86559aa784b0URI
-
https://doi.org/10.1097/GOX.0000000000004671DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
UNLABELLED: Lymphedema is a chronic, debilitating disease that has been described as the largest breast cancer survivorship burden. Debulking surgery has been shown to improve extremity volume, improve patient quality of life, and decrease the incidence of cellulitis in the literature. This procedure is routinely covered in numerous other developed countries, yet it is still inconsistently covered in the United States.METHODS: Extremity volumes from all patients who underwent debulking surgery of the upper extremity at two institutions between December 2017 and January 2020 with at least 12 months follow-up were included. Procedural costs were calculated using Medicare reimbursement data. Average utility scores were obtained for each health state using a visual analog scale, then converted to quality-adjusted life years. A decision tree was generated, and incremental cost-utility ratios were calculated. Sensitivity analyses were performed to evaluate our findings.RESULTS: Debulking surgery is associated with a higher clinical effectiveness (quality-adjusted life year) of 27.05 compared to conservative management (23.34), with a relative cost reduction of $74,487. Rollback analysis favored debulking surgery as the cost-effective option compared to conservative management. The resulting negative incremental cost-utility ratio of -20,115.07 favored debulking surgery and indicated a dominant strategy.CONCLUSION: Our study supports the use of debulking surgery for the treatment of chronic lymphedema of the upper extremity.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Granoff, MelisaBeth Israel Deaconess Medical Center
(author)
-
Karlsson, TobiasLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Skåne University Hospital(Swepub:lu)to1487ka
(author)
-
Greene, Arin KBoston Children's Hospital
(author)
-
Brorson, HåkanLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Surgery,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital(Swepub:lu)plas-hbr
(author)
-
Chatterjee, AbhishekTufts Medical Center
(author)
-
Singhal, DhruvBeth Israel Deaconess Medical Center
(author)
-
Tufts Medical CenterBeth Israel Deaconess Medical Center
(creator_code:org_t)
Related titles
-
In:Plastic and reconstructive surgery. Global open10:112169-7574
Internet link
Find in a library
To the university's database